Aarti Drugs Launches 'Saksham Niveshak' Campaign for Unclaimed Dividends

Disclaimer This is an AI-assisted live blog with updates sourced from multiple news outlets and agencies Disclaimer

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Aarti Drugs Limited has launched the 'Saksham Niveshak' campaign, responding to the Investor Education and Protection Fund Authority's (IEPFA) request to reach out to shareholders with unclaimed dividends. The campaign, which runs from July 28, 2025, to November 6, 2025, aims to update KYC details and facilitate the claiming of unpaid dividends before they are transferred to the IEPF.

The company has urged shareholders to update their PAN, nomination details, contact information, and bank account details with MUFG Intime India Private Limited or their Depository Participant. This update ensures that dividends are credited electronically to the correct bank accounts.

To facilitate this process, shareholders can submit the following documents:

• Form ISR-1: Filled and signed, with self-attested KYC documents.
• Form ISR-2: Filled and signed, with banker's attestation and an original cancelled cheque or self-attested bank passbook/statement.
• Form SH-13: For adding a nominee.
• Form ISR-3: If opting out of nomination.

These documents can be submitted via post to MUFG Intime India Private Limited at C 101, 247 Embassy, L B S Marg, Vikhroli West, Mumbai 400083, or via email to rnt.helpdesk@in.mpms.mufg.com with digitally signed documents. Shareholders can also upload documents online through the MUFG portal at https://in.mpms.mufg.com/.

Aarti Drugs has also posted details of unclaimed dividends for the past seven years on its website at https://www.aartidrugs.co.in/unclaimed-dividend/. The company noted that dividends cannot be paid if bank details are not registered and that equity shares related to unclaimed dividends for seven consecutive years will be transferred to the IEPF Authority.

Shareholders are encouraged to submit their documents by November 6, 2025. For further assistance, they can contact Aarti Drugs Limited at investorrelations@aartidrugs.com or +91 22 24048199, or MUFG Intime India Private Limited at rnt.helpdesk@in.mpms.mufg.com or +91 810 811 6767.

RUSHIKESH DEOLE
COMPANY SECRETARY & COMPLIANCE OFFICER